ABOUT US

The Infusion Providers Alliance is a leading voice for in-office and freestanding ambulatory facility providers of drug infusion services.

Alliance members are committed to preserving the integrity of the provider-patient relationship in a manner that delivers exceptional care to patients at a value to the health care system.

The Infusion Providers Alliance mission is to serve as a thought leader and to educate on issues critical to safeguarding, supporting, and strengthening provider directed, patient-focused access to in-office and freestanding ambulatory facility infusion services.

Drug Infusion Services
Our members have facilities located in communities across the nation, each of which offers a more convenient, more efficient and less expensive alternative for patients than receiving their infusions in the hospital setting. These facilities serve as critical access points of care for patients and save tremendous dollars for commercial and government payers alike while also lowering out of pocket costs for beneficiaries.

OUR POLICIES

Policy Values

Government

Promote and preserve patient access to infused products through in-office and freestanding ambulatory infusion providers;

Reduce healthcare system drug spending by promoting increased utilization of more efficient provider in-office and freestanding ambulatory facility infusions in lieu of hospital administration;

Improve patient adherence and minimize wastage by protecting the current and reliable infused drug distribution systems, which allows provider offices and freestanding ambulatory facility providers to retain the inventory available to accommodate patient dosage changes;

Field

Ensure that there is a level-playing field across all delivery channels ranging from specialty pharmacies, home-infusion, hospital outpatient infusion, in-office infusion providers and freestanding ambulatory facility infusion providers.

Reimbursement

Ensure appropriate drug administration reimbursement for infused therapies for all patients treated in the in-office and freestanding ambulatory facility setting;

Advocate for the provider prescribing authority to direct patient care and adherence to prescribed infusion drugs by opposing PBM and health insurance policies that undermine the provider-patient relationship; and

Otherwise advocate for the professional interests of non-hospital, community-based infusion providers.

Learn more about specific policy positions.

LEADERSHIP

Executive Director

Elliott Warren, Executive Director of Infusion Providers Alliance

Elliott Warren

Background

Elliott Warren, Executive Director, joined the Infusion Providers Alliance (IPA) in May of 2025. In this role, he advocates for appropriate patient access to provider administered drugs within IPA members’ non-hospital, community-based settings. He oversees all managerial responsibilities for the Alliance. Prior to joining IPA, Elliott spent over 13 years at the Medical Device Manufacturers Association (MDMA) and most recently served as MDMA’s Vice President of Outreach & Engagement. He received an MBA from Georgetown University’s McDonough School of Business and a BA from the University of Mississippi’s Trent Lott Leadership Institute.

CORPORATE PARTNERS

Gold Partners

Amgen logo
Boehringer Ingelheim logo
Horizon Therapeutics logo

Silver Partners

BioGen logo
BioGen logo
BioGen logo
PhRMA logo
PhRMA logo
PhRMA logo
UCB logo

Bronze Partners

Genentech logo

COST SAVINGS AND IMPROVED QUALITY
IN A CLINIC BASED SETTING

The Clinic-Based Approach Results in
Substantial Savings and Better Outcomes.